You are using an outdated browser. Please upgrade your browser to improve your experience.

congenital myasthenic syndrome 6

Disease Summary
Associated Targets (1)
Tchem

1


GARD Rare
Mondo Description Congenital myasthenic syndrome caused by mutation(s) in the CHAT gene, encoding choline O-acetyltransferase. It is inherited in an autosomal recessive manner.
Uniprot Description A form of congenital myasthenic syndrome, a group of disorders characterized by failure of neuromuscular transmission, including pre-synaptic, synaptic, and post-synaptic disorders that are not of autoimmune origin. Clinical features are easy fatigability and muscle weakness affecting the axial and limb muscles (with hypotonia in early-onset forms), the ocular muscles (leading to ptosis and ophthalmoplegia), and the facial and bulbar musculature (affecting sucking and swallowing, and leading to dysphonia). The symptoms fluctuate and worsen with physical effort. CMS6 affected individuals have myasthenic symptoms since birth or early infancy, negative tests for anti-AChR antibodies, and abrupt episodic crises with increased weakness, bulbar paralysis, and apnea precipitated by undue exertion, fever, or excitement. CMS6 inheritance is autosomal recessive.
Mondo Term and Equivalent IDs
MONDO:0009689:  congenital myasthenic syndrome 6
GARD:0009689: 
MESH:C535759: 
NCIT:C132292: 
SCTID:230670003: 
UMLS:C0393929: